Chemotherapy resistance-associated epithelial to endothelial transition in gastric cancer

S Peri, A Biagioni, F Cianchi, I Skalamera, F Staderini, N Schiavone, L Papucci, L Magnelli

Article ID: 6439
Vol 32, Issue 4S1, 2018
DOI: https://doi.org/10.54517/jbrha6439
Received: 8 September 2018; Accepted: 8 September 2018; Available online: 8 September 2018; Issue release: 8 September 2018

Abstract

Gastric cancer (GC) is the fifth most common cancer worldwide and the third leading cause of cancer-related deaths. To date, gastrectomy and chemotherapy are the only therapeutic options, but drug resistance is the main cause for treatment failure. Vasculogenic mimicry (VM) is a new model of neovascularization in aggressive tumors and has been correlated with poor prognosis in GC patients. Our group has developed chemotherapy-resistant GC cells using the Caucasian adenocarcinoma cell line AGS and three drugs among the most used in clinic (5-fluorouracil, cisplatin and paclitaxel) henceforward denominated 5FUr, CISr, TAXr. Our study has highlighted phenotypical differences among chemo-sensitive and chemo-resistant cell lines such as acquisition of stem-like phenotype and increased capacity to form vessels.



References

Supporting Agencies



Copyright (c) 2018 S Peri, A Biagioni, F Cianchi, I Skalamera, F Staderini, N Schiavone, L Papucci, L Magnelli




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).